Cancer-associated hemolytic-uremic syndrome with spontaneous resolution. A case report.
A case of cancer-related hemolytic-uremic syndrome is reported. The patient presented a spontaneous recovery, which is unusual in this clinical picture. Mitomycin C is regarded as responsible for this toxic event in most cases. The case history reported here is discussed in relation to dose and scheduling of mitomycin C, and a safe maximum dosage is suggested.
Seminara
P
P
Istituto di Clinica Medica III, Università La Sapienza, Roma, Italy.
Franchi
F
F
Abdolrahimzadeh
S
S
Gozzer
M
M
Barone
C
C
D000970:Antineoplastic Agents / Q000627:therapeutic use; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use; D006463:Hemolytic-Uremic Syndrome / Q000209:etiology*; D006801:Humans; D008875:Middle Aged; D016685:Mitomycin; D008937:Mitomycins / Q000627:therapeutic use; D012004:Rectal Neoplasms / Q000150:complications* / Q000188:drug therapy; D012075:Remission, Spontaneous
D000970:Antineoplastic Agents; D008937:Mitomycins; D016685:Mitomycin; D005472:Fluorouracil